| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in MBX over the last quarter tilts toward selling: insiders offloaded a net 370 shares worth roughly $24K.
Classified under Biotechnology (Health Care sector), MBX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 727.7K | $21.50M | - | |
| CEO | 82.9K | - | - | |
| CFO | 28.0K | - | - | |
| CFO | 15.0K | - | - | |
| Other | 14.4K | $947.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2024 | Walker Paul Edward47 | 10% Owner | Buy | 500,000 | $16.00 | $8,000,000.00 | +16.1% | -11.6% | -55.0% | |
| Sep 16, 2024 | Yang Rick | 10% Owner | Buy | 500,000 | $16.00 | $8,000,000.00 | +16.1% | -11.6% | -55.0% | |
| Sep 16, 2024 | Sandell Scott D55 | 10% Owner | Buy | 500,000 | $16.00 | $8,000,000.00 | +16.1% | -11.6% | -55.0% | |
| Sep 16, 2024 | Orbimed Advisors LLC66 | Director, 10% Owner | Buy | 750,000 | $16.00 | $12,000,000.00 | -779.5% | -11.6% | -55.0% | |
| Sep 16, 2024 | New Enterprise Associates 17, L.P. | 10% Owner | Buy | 500,000 | $16.00 | $8,000,000.00 | +16.1% | -11.6% | -55.0% | |
| Sep 16, 2024 | Aynechi Tiba | Director | Buy | 750,000 | $16.00 | $12,000,000.00 | +54.1% | -11.6% | -55.0% | |
| Sep 16, 2024 | Gordon Carl L74 | Director, 10% Owner | Buy | 750,000 | $16.00 | $12,000,000.00 | -779.5% | -11.6% | -55.0% |